{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:36:49Z","timestamp":1777012609770,"version":"3.51.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Dipeptidyl peptidase-1 (DPP1) is a lysosomal cysteine protease essential for activating neutrophil serine proteases (NSPs), including neutrophil elastase, cathepsin G, and proteinase 3, during neutrophil differentiation in the bone marrow. Because NSP-mediated tissue damage contributes to chronic inflammatory and autoimmune diseases, targeting NSPs has emerged as a therapeutic strategy. In this regard, small molecule drugs have been developed such as brensocatib\u2013a competitive, reversible DPP1 inhibitor. Active DPP1 is expressed in mature neutrophils, which raises the possibility that DPP1 inhibition might affect more than just NSP activities. Here, we investigated the effects of DPP1 and NSP inhibition or ablation on neutrophil function using brensocatib, as well as\n                    <jats:italic>DPP1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    and triple NSP knockout (\n                    <jats:italic>NE<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    <jats:italic>CatG<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    <jats:italic>Pr3<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    ) mice. As expected, DPP1 inhibition with brensocatib during mouse bone marrow hematopoietic stem cell differentiation dose-dependently reduced NSP activities. While DPP1 inhibition or ablation suppressed neutrophil extracellular trap (NET) formation in mice, it had no significant impact on granulocytic differentiation, migration, phagocytosis, reactive oxygen species production, or bacterial killing. A similar outcome was observed in triple NSP KO mice. In mature human neutrophils, brensocatib had no effect on any of these responses, including NET formation. These findings suggest that while DPP1 is crucial for NSP activation during early neutrophilic differentiation, it does not substantially influence differentiation itself or core neutrophil functions, except for NET formation in mice. This study advances our understanding of the roles of DPP1 and NSPs in neutrophil biology and further emphasizes the high selectivity of brensocatib in the main target cells.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1689804","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:40:52Z","timestamp":1777009252000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of dipeptidyl peptidase I and neutrophil serine proteases on neutrophil functional responses"],"prefix":"10.3389","volume":"17","author":[{"given":"Dedong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Ju","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandita","family":"Niranjan","sequence":"additional","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Basso","sequence":"additional","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"LaSala","sequence":"additional","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Fong","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"de Carvalho Oliveira","sequence":"additional","affiliation":[{"name":"Immunology Graduate Program, Faculty of Medicine, Universit\u00e9 de Sherbrooke","place":["Sherbrooke, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Cipolla","sequence":"additional","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick P.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Department of Research, Insmed Incorporated","place":["Bridgewater, NJ, United States"]},{"name":"Immunology Graduate Program, Faculty of Medicine, Universit\u00e9 de Sherbrooke","place":["Sherbrooke, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1172\/JCI13462","article-title":"Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis","volume":"109","author":"Adkison","year":"2002","journal-title":"J. Clin. Invest."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0272575","DOI":"10.1371\/journal.pone.0272575","article-title":"An optimized method of extracting and quantifying active neutrophil serine proteases from human whole blood cells","volume":"17","author":"Basso","year":"2022","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1208780","DOI":"10.3389\/fphar.2023.1208780","article-title":"The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species","volume":"14","author":"Basso","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","article-title":"The neutrophil","volume":"54","author":"Burn","year":"2021","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1239151","DOI":"10.3389\/fimmu.2023.1239151","article-title":"Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease","volume":"14","author":"Chalmers","year":"2023","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"65:2401050","DOI":"10.1183\/13993003.01050-2024","article-title":"Targeting neutrophil serine proteases in bronchiectasis","author":"Chalmers","year":"","journal-title":"Eur. Respir. J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"392","author":"Chalmers","year":"","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1185727","DOI":"10.3389\/fimmu.2023.1185727","article-title":"Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-alpha-accelerated lupus nephritis in mice","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s12967-024-05589-7","article-title":"Cathepsin C in health and disease: from structural insights to therapeutic prospects","volume":"22","author":"Chitsamankhun","year":"2024","journal-title":"J. Transl. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12931-023-02444-z","article-title":"Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial","volume":"24","author":"Cipolla","year":"2023","journal-title":"Respir. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1042686","DOI":"10.3389\/fimmu.2023.1042686","article-title":"Phosphoinositol 3-kinase-driven NET formation involves different isoforms and signaling partners depending on the stimulus","volume":"14","author":"de Carvalho Oliveira","year":"2023","journal-title":"Front. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"102888","DOI":"10.1016\/j.xpro.2024.102888","article-title":"Protocol to create a murine subcutaneous air pouch for the study of monosodium urate crystal-induced gout","volume":"5","author":"Devi","year":"2024","journal-title":"Star. Protoc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"9457","DOI":"10.1021\/acs.jmedchem.6b01127","article-title":"Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)","volume":"59","author":"Doyle","year":"2016","journal-title":"J. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.4049\/jimmunol.175.3.1834","article-title":"Constitutive nuclear expression of the I kappa B kinase complex and its activation in human neutrophils","volume":"175","author":"Ear","year":"2005","journal-title":"J. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/0471142735.im22f05s104","article-title":"Differentiation and characterization of myeloid cells","volume":"104","author":"Gupta","year":"2014","journal-title":"Curr. Protoc. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1004593","DOI":"10.1371\/journal.ppat.1004593","article-title":"DNA is an antimicrobial component of neutrophil extracellular traps","volume":"11","author":"Halverson","year":"2015","journal-title":"PLoS Pathog."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8486","DOI":"10.1074\/jbc.M115.707109","article-title":"Neutrophilic cathepsin C is maturated by a multistep proteolytic process and secreted by activated cells during inflammatory lung diseases","volume":"291","author":"Hamon","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1038\/s41590-024-02006-5","article-title":"The diverse roles of neutrophils from protection to pathogenesis","volume":"25","author":"Herro","year":"2024","journal-title":"Nat. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1165\/rcmb.2003-0253OC","article-title":"Deficiency in neutrophil elastase does not impair neutrophil recruitment to inflamed sites","volume":"30","author":"Hirche","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1164\/rccm.202408-1545OC","article-title":"Broad immunomodulatory effects of the Dipeptidyl-peptidase-1 inhibitor brensocatib in bronchiectasis: data from the phase 2, double-blind, placebo-controlled WILLOW trial","volume":"211","author":"Johnson","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"gkae1262","DOI":"10.1093\/nar\/gkae1262","article-title":"Neutrophil extracellular traps have DNAzyme activity that drives bactericidal potential","volume":"53","author":"Ku","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1165\/ajrcmb.20.6.3539","article-title":"Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors","volume":"20","author":"Mackarel","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1231047","DOI":"10.3389\/fimmu.2023.1231047","article-title":"Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis","volume":"14","author":"McDonald","year":"2023","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","article-title":"A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis","volume":"8","author":"Metzler","year":"2014","journal-title":"Cell Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J. Cell Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nri1841","article-title":"Neutrophil serine proteases: specific regulators of inflammation","volume":"6","author":"Pham","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.biocel.2007.11.008","article-title":"Neutrophil serine proteases fine-tune the inflammatory response","volume":"40","author":"Pham","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.1073\/pnas.96.15.8627","article-title":"Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo","volume":"96","author":"Pham","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.4049\/jimmunol.173.12.7277","article-title":"Papillon-lefevre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C\/dipeptidyl peptidase I deficiency in humans","volume":"173","author":"Pham","year":"2004","journal-title":"J. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.7150\/thno.96092","article-title":"Targeting cathepsin C ameliorates murine acetaminophen-induced liver injury","volume":"14","author":"Raith","year":"2024","journal-title":"Theranostics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"113818","DOI":"10.1016\/j.ejmech.2021.113818","article-title":"Cathepsin C inhibitors as anti-inflammatory drug discovery: challenges and opportunities","volume":"225","author":"Shen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI76009","article-title":"Papillon-lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses","volume":"124","author":"Sorensen","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1396710","DOI":"10.3389\/fphar.2024.1396710","article-title":"Pharmacologic inhibition of dipeptidyl peptidase 1 (Cathepsin C) does not block in vitro granzyme-mediated target cell killing by CD8 T or NK cells","volume":"15","author":"Sutton","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"675315","DOI":"10.3389\/fimmu.2021.675315","article-title":"Early and late processes driving NET formation, and the Autocrine\/Paracrine role of endogenous RAGE ligands","volume":"12","author":"Tatsiy","year":"2021","journal-title":"Front. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/pharmaceutics13010010","article-title":"Effect of diphenyleneiodonium chloride on intracellular reactive oxygen species metabolism with emphasis on NADPH oxidase and mitochondria in two therapeutically relevant human cell types","volume":"13","author":"Zavadskis","year":"2020","journal-title":"Pharmaceutics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41392-024-02049-y","article-title":"Neutrophil diversity and function in health and disease","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1689804\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:40:53Z","timestamp":1777009253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1689804\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":38,"alternative-id":["10.3389\/fphar.2026.1689804"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1689804","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1689804"}}